Curcumin was shown to inhibit epithelial–mesenchymal transition (EMT) and angiogenesis in HGF-induced lung cancer cells by regulating c-Met-dependent PI3K/Akt/mTOR signaling pathways [151]. The gene discussed is AKT1; the disease is lung cancer.